Marfan syndrome and its disorder in periodontal tissues
✍ Scribed by Naoto Suda; Momotoshi Shiga; Ganjargal Ganburged; Keiji Moriyama
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 181 KB
- Volume
- 312B
- Category
- Article
- ISSN
- 1552-5007
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Elastic system fibers are composed of two distinct elements, elastin, which is an amorphous component crosslinked in the core, and microfibril, localized in the periphery of elastin. As microfibrillar proteins, fibrillins, microfibril‐associated glycoproteins (MAGPs), latent TGF‐β‐binding proteins (LTBPs), microfibril‐associated proteins (MFAPs), and fibulins are known. Fibrillin‐1 is a major microfibrillar protein and characterized by calcium binding EGF‐like (cbEGF) domain. Association between fibrillin‐1 and TGF‐β is a recent topic of this field and this interaction is known to inactivate and target TGF‐β action. FBN1 encoding fibrillin‐1 is a responsible gene for Marfan syndrome type 1 (MIM ♯154700), characterized by increased height and long limbs, ectopia lentis, and cardiovascular disorders, such as mitral valve prolapse and aortic dilation and regurgitation. Animal models suggest that the abnormal TGF‐β signaling is underlying as the pathogenesis of these conditions. Besides skeletal, ocular and cardiovascular conditions, severe periodontitis is frequently seen in affected patients. To clarify the unknown function of elastic system fibers in the periodontal ligament (PDL), PDL‐cells were isolated from a Marfan syndrome type 1 patient who was with the severe periodontitis and had a mutation in one of the cbEGF domain of fibrillin‐1. These results suggested that wild‐type fibrillin‐1 was required for the normal cell alignment and tissue architecture of PDLs. Evidences are now accumulated to suggest that fibrillin‐1 is one of the molecule involved in the interaction between cell and extracellular matrix. J. Exp. Zool. (Mol. Dev. Evol.) 312B:503–509, 2009. © 2009 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Marfan syndrome (MFS), a multisystem autosomal-dominant disorder, is characterized by mutations of the fibrillin-1 (FBNI) gene and by abnormal patterns of synthesis, secretion, and matrix deposition of the fibrillin protein. To determine the sensitivity and specificity of fibrillin protein abnormali
Mutations in the FBN1 gene have been characterised in patients affected by Marfan syndrome and Marfan-related disorders. Starting with genomic DNA, we analysed the FBN1 gene using PCR, SSCP and/or dHPLC analysis, and automatic sequencing of abnormal bands/peaks, in a consecutive series of 508 patien
## Abstract Bovine Marfan syndrome has all the major pathognomonic, clinical, and pathological features of the human syndrome. To further explore the alterations characterizing Marfan syndrome, musculoskeletal tissues from affected and healthy cattle were subjected to histochemical and histomorphom
## Marfan syndrome (MFS) is an autosomal dominant trait due to mutations in the fibrillin gene (FBN1). The MFS expressivity is variable, and its diagnosis relies completely on clinical criteria. Atypical cases and Marfan-like (marfanoid) clinical presentations are commonly found. The metacarpophal